ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $69,195 | +15.0% | 1,500 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $60,150 | -13.4% | 1,500 | 0.0% | 0.01% | -14.3% |
Q4 2022 | $69,495 | +12.1% | 1,500 | 0.0% | 0.01% | +16.7% |
Q3 2022 | $62,000 | -30.3% | 1,500 | 0.0% | 0.01% | -33.3% |
Q2 2022 | $89,000 | -18.3% | 1,500 | 0.0% | 0.01% | +28.6% |
Q1 2022 | $109,000 | -13.5% | 1,500 | 0.0% | 0.01% | -12.5% |
Q4 2021 | $126,000 | -6.7% | 1,500 | 0.0% | 0.01% | -11.1% |
Q3 2021 | $135,000 | -5.6% | 1,500 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $143,000 | -16.4% | 1,500 | 0.0% | 0.01% | -25.0% |
Q1 2021 | $171,000 | -17.8% | 1,500 | 0.0% | 0.01% | -29.4% |
Q4 2020 | $208,000 | +69.1% | 1,500 | 0.0% | 0.02% | +54.5% |
Q3 2020 | $123,000 | +5.1% | 1,500 | 0.0% | 0.01% | +22.2% |
Q2 2020 | $117,000 | +74.6% | 1,500 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $67,000 | +4.7% | 1,500 | 0.0% | 0.01% | +20.0% |
Q4 2019 | $64,000 | -47.5% | 1,500 | -47.4% | 0.01% | -54.5% |
Q3 2019 | $122,000 | -32.6% | 2,850 | 0.0% | 0.01% | -45.0% |
Q2 2019 | $181,000 | -8.6% | 2,850 | 0.0% | 0.02% | -16.7% |
Q1 2019 | $198,000 | +59.7% | 2,850 | 0.0% | 0.02% | +41.2% |
Q4 2018 | $124,000 | -26.2% | 2,850 | +29.5% | 0.02% | -19.0% |
Q3 2018 | $168,000 | -0.6% | 2,200 | 0.0% | 0.02% | -8.7% |
Q2 2018 | $169,000 | +50.9% | 2,200 | 0.0% | 0.02% | +53.3% |
Q1 2018 | $112,000 | +9.8% | 2,200 | 0.0% | 0.02% | 0.0% |
Q4 2017 | $102,000 | – | 2,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |